相似文献
1
Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China.
Chin Med J (Engl). 2018 Oct 5;131(19):2388-2389. doi: 10.4103/0366-6999.241814.
2
Cysteamine for cystinosis.
Med Lett Drugs Ther. 1994 Dec 23;36(938):118.
3
Therapy of cystinosis.
Prog Clin Biol Res. 1985;197:157-62.
4
A cost-effectiveness analysis of the orphan drug cysteamine in the treatment of infantile cystinosis.
Med Decis Making. 1997 Apr-Jun;17(2):193-8. doi: 10.1177/0272989X9701700210.
5
Approval of cysteamine for patients with cystinosis.
Pediatr Nephrol. 1995 Apr;9(2):254. doi: 10.1007/BF00860767.
6
Nephropathic cystinosis: effect of long-term cysteamine therapy.
Clin Nephrol. 1987 Jun;27(6):309-12.
7
[The treatment of cystinosis with cysteamine].
Ann Pediatr (Paris). 1991 Jun;38(6):440.
8
Treatment of cystinosis with cysteamine.
J Pediatr. 1979 May;94(5):838-40. doi: 10.1016/s0022-3476(79)80174-2.
9
Cysteamine treatment of nephropathic cystinosis.
Prog Clin Biol Res. 1983;127:125-31.
10
[Treatment of cystinosis with cysteamine].
Presse Med. 1983 Jan 22;12(3):167-8.
引用本文的文献
1
Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective.
Pediatr Nephrol. 2024 Apr;39(4):1113-1123. doi: 10.1007/s00467-023-06179-3. Epub 2023 Nov 18.
2
Analysis on the Marketing Trend and Approval Lag of Imported Orphan Drugs from 2010 to 2021 in China.
Ther Innov Regul Sci. 2023 Nov;57(6):1314-1321. doi: 10.1007/s43441-023-00572-8. Epub 2023 Aug 31.
3
A systematic review of moral reasons on orphan drug reimbursement.
Orphanet J Rare Dis. 2021 Jun 30;16(1):292. doi: 10.1186/s13023-021-01925-y.
本文引用的文献
1
Effects of long-term cysteamine treatment in patients with cystinosis.
Pediatr Nephrol. 2019 Apr;34(4):571-578. doi: 10.1007/s00467-017-3856-4. Epub 2017 Dec 19.
2
Cystinosis: a review.
Orphanet J Rare Dis. 2016 Apr 22;11:47. doi: 10.1186/s13023-016-0426-y.
3
Rare disease patients in China anticipate the sunlight of legislation.
Drug Discov Ther. 2013 Jun;7(3):126-8.
4
China's first rare-disease registry is under development.
Lancet. 2011 Aug 27;378(9793):769-70. doi: 10.1016/S0140-6736(11)61375-5.
5
Rare diseases and legislation in China.
Lancet. 2010 Feb 27;375(9716):708-9. doi: 10.1016/S0140-6736(10)60240-1.
6
Cystinosis.
N Engl J Med. 2002 Jul 11;347(2):111-21. doi: 10.1056/NEJMra020552.
7
Long-term treatment with growth hormone in short children with nephropathic cystinosis.
J Pediatr. 2001 Jun;138(6):880-7. doi: 10.1067/mpd.2001.113263.
8
Improved renal function in children with cystinosis treated with cysteamine.
N Engl J Med. 1993 Apr 22;328(16):1157-62. doi: 10.1056/NEJM199304223281604.
Zotero 插件